Points of View

Pharma firms must look to Cognizant’s growing capabilities as it invests in IOT and life sciences


In the noisy and hyper-competitive IT services market, it pays to be clear. However, being clear to the market doesn’t seem to be on Brian Humphries to-do list. In previous analysis, we examined how Cognizant’s leadership change earlier in the year could have been an issue because the new CEO went on a parade of internal rationalizations and cost-cutting. And yet—despite an internal savings drive, the firm just acquired Zenith Technologies, an innovator in life sciences, which bodes well for the many pharma and life sciences firms already on Cognizant’s books for IT services. Existing Cognizant clients must make use of this new capability to transform their manufacturing practices with advanced IoT solutions.


Sign in or register an account to access HFS' Content

Sign In

Create an account

Enter a phone number
Select the newsletter(s) to which you wish to subscribe.